Delivery Order SPE2DB22D3016-SPE2DB25FAJY2

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, with a firm fixed price and a ceiling value of $5,154.61. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,484.43, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of 4566572752 ! DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through December 2, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,365.62 firm fixed-price delivery order is for the supply of 4566340909 - Dorzolamide-Timolol Eye Drops 10ML. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,888.01 firm fixed-price delivery order is for the supply of Dorzolamide-Timolol eye drops, which are used to treat glaucoma and elevated eye pressure. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. It is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,442.75, is for the delivery of Dorzolamide-Timolol eye drops, a pharmaceutical product used for the treatment of eye conditions. The contract is a delivery order, with a firm-fixed price pricing type and an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,838.40 firm fixed price delivery order is for the provision of DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The award is part of a larger $999,999,999.00 indefinite delivery contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,663.23 firm fixed-price contract is for the delivery of 4567074296 - DORZOLAMIDE-TIMOLOL EYE DROPS 10ML. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of dorzolamide-timolol eye drops, a prescription medication, valued at $5,129.75. This is a firm fixed-price delivery order contract with a completion date of January 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.02 firm fixed-price delivery order is for the supply of Dorzolamide-Timolol eye drops, a medication used to treat glaucoma. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC...
This federal contract award, valued at $1,052.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dorzolamide HCL 2% eye drops, a pharmaceutical product used for the treatment of glaucoma. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJY2
    Delivery Order

This federal contract award, valued at $1,499.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, a medical product used in the treatment of various eye conditions.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through open competition.

Generated 4/21/25, 3:58 AM